[1]ZHENG RS,ZUO TT,ZENG HM,et al.Mortality and survival analysis of liver cancer in China[J].Chin J Oncol,2015,37(9):697-702.(in Chinese)郑荣寿,左婷婷,曾红梅,等.中国肝癌死亡状况与生存分析[J].中华肿瘤杂志,2015,37(9):697-702.
|
[2]ZUO TT,ZHENG RS,ZENG HM,et al.Analysis of liver cancer incidence and trend in China[J].Chin J Oncol,2015,37(9):691-696.(in Chinese)左婷婷,郑荣寿,曾红梅,等.中国肝癌发病状况与趋势分析[J].中华肿瘤杂志,2015,37(9):691-696.
|
[3]LI L,BONNETON F,TOHME M,et al.In vivo screening using transgenic zebrafish embryos reveals new effects of HDAC inhibitors trichostatin A and valproic acid on organogenesis[J].PLoS One,2016,11(2):e0149497.
|
[4]FARMEN E,HULTMAN MT,ANGLS D'AURIAC M,et al.Development of a screening system for the detection of chemically induced DNA methylation alterations in a zebrafish liver cell line[J].J Toxicol Environ Health A,2014,77(9-11):587-599.
|
[5]LIN TY,CHOU CF,CHUNG HY,et al.Hypoxia-inducible factor 2 alpha is essential for hepatic outgrowth and functions via the regulation of leg1 transcription in the zebrafish embryo[J].PLoSOne,2014,9(7):e101980.
|
[6]SPITSBERGEN JM,TSAI HW,REDDY A,et al.Neoplasia in zebrafish(Danio rerio)treated with 7,12-dimethylbenz[a]-anthracene by two exposure routes at different developmental stages[J].Toxicol Pathol,2000,28(5):705-715.
|
[7]LU JW,YANG WY,TSAI SM,et al.Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish[J].PLoS One,2013,8(10):e76951.
|
[8]SUN L,NGUYEN AT,SPITSBERGEN JM,et al.Myc-induced liver tumors in transgenic zebrafish can regress in tp53 null mutation[J].PLoS One,2015,10(1):e0117249.
|
[9]HARAMIS AP,HURLSTONE A,van der VELDEN Y,et al.Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia[J].EMBO Rep,2006,7(4):444-449.
|
[10]EVASON KJ,FRANCISCO MT,JURIC V,et al.Identification of chemical inhibitors ofβ-catenin-driven liver tumorigenesis in zebrafish[J].PLoS Genet,2015,11(7):e1005305.
|
[11]NGUYEN AT,KOH V,SPITSBERGEN JM,et al.Development of a conditional liver tumor model by mifepristone-inducible Cre recombination to control oncogenic kras(V12)expression in transgenic zebrafish[J].Sci Rep,2016,6:19559.
|
[12]YAN C,HUO X,WANG S,et al.Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish[J].J Hepatol,2015,63(2):420-428.
|
[13]CHEW TW,LIU XJ,LIU L,et al.Crosstalk of Ras and Rho:activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models[J].Oncogene,2014,33(21):2717-2727.
|
[14]LI Z,ZHENG W,LI H,et al.Synergistic induction of potential warburg effect in zebrafish hepatocellular carcinoma by co-transgenic expression of myc and xmrk oncogenes[J].PLoS One,2015,10(7):e0132319.
|
[15]LI Z,LUO H,LI C,et al.Transcriptomic analysis of a transgenic zebrafish hepatocellular carcinoma model reveals a prominent role of immune responses in tumour progression and regression[J].Int JCancer,2014,135(7):1564-1573.
|
[16]ZHENG W,LI Z,NGUYEN AT,et al.Xmrk,kras and myc transgenic zebrafish liver cancer models share molecular signatures with subsets of human hepatocellular carcinoma[J].PLoS One,2014,9(3):e91179.
|
[17]CUI J,SIM TH,GONG Z,et al.Generation of transgenic zebrafish with liver-specific expression of EGFP-Lc3:a new in vivo model for investigation of liver autophagy[J].Biochem Biophys Res Commun,2012,422(2):268-273.
|
[18]JENSEN LD.The circadian clock and hypoxia in tumor cell de-differentiation and metastasis[J].Biochim Biophys Acta,2015,1850(8):1633-1641.
|
[19]OEHLERS SH,CRONAN MR,SCOTT NR,et al.Interception of host angiogenic signalling limits mycobacterial growth[J].Nature,2015,517(7536):612-615.
|
[20]ELKS PM,RENSHAW SA,MEIJER AH,et al.Exploring the HIFs,buts and maybes of hypoxia signalling in disease:lessons from zebrafish models[J].Dis Model Mech,2015,8(11):1349-1360.
|
[21]BRUTIGAM L,PUDELKO L,JEMTH AS,et al.Hypoxic signaling and the cellular redox tumor environment determine sensitivity to MTH1inhibition[J].Cancer Res,2016,76(8):2366-2375.
|
[22]SANTHAKUMAR K,JUDSON EC,ELKS PM,et al.A zebrafish model to study and therapeutically manipulate hypoxia signaling in tumorigenesis[J].Cancer Res,2012,72(16):4017-4027.
|
[23]SINGLETON DC,ROUHI P,ZOIS CE,et al.Hypoxic regulation of RIOK3 is a major mechanism for cancer cell invasion and metastasis[J].Oncogene,2015,34(36):4713-4722.
|
[24]KREMER-TAL S,REEVES HL,NARLA G,et al.Frequent inactivation of the tumor suppressor Krüppel-like factor 6(KLF6)in hepatocellular carcinoma[J].Hepatology,2004,40(5):1047-1052.
|
[25]LANG UE,KOCABAYOGLU P,CHENG GZ,et al.GSK3βphosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21[J].Oncogene,2013,32(38):4557-4564.
|
[26]DIAB T,HANOUN N,BUREAU C,et al.The Role of the 3'untranslated region in the post-transcriptional regulation of KLF6gene expression in hepatocellular carcinoma[J].Cancers(Basel),2013,6(1):28-41.
|
[27]LIANG WC,WANG Y,XIAO LJ,et al.Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform[J].RNA Biol,2014,11(7):845-854.
|
[28]ZHAO X,MONSON C,GAO C,et al.Klf6/copeb is required for hepatic outgrowth in zebrafish and for hepatocyte specification in mouse ES cells[J].Dev Biol,2010,344(1):79-93.
|
[29]ABE H,OGAWA T,WANG L,et al.Promoter-region hypermethylation and expression downregulation of Yy1(Yin yang 1)in preneoplastic liver lesions in a thioacetamide rat hepatocarcinogenesis model[J].Toxicol Appl Pharmacol,2014,280(3):467-474.
|
[30]SHAN X,REN M,CHEN K,et al.Regulation of the microRNA processor DGCR8 by hepatitis B virus proteins via the transcription factor YY1[J].Arch Virol,2015,160(3):795-803.
|
[31]YE SL.Current challenges to primary liver cancer research[J].JClin Hepatol,2015,31(6):819-823.(in Chinese)叶胜龙.原发性肝癌研究当前面临的挑战[J].临床肝胆病杂志,2015,31(6):819-823.
|
[32]DENG X,WU JB.Updates in the research of relationship between MicroRNAs and hepatocellular carcinoma[J].Chin J Dig Surg,2015,14(5):431-433.(in Chinese)邓曦,吴敬波.微RNAs与肝癌关系的研究进展[J].中华消化外科杂志,2015,14(5):431-433.
|